Type Of Business:
Pharmaceutical company
Marketing Area:
International
Expertise:
Clinical research
Major Product/SVS:
Pharmaceutical services and products
Hobbies/Sports:
Swimming; Scuba diving; Cooking; Reading; Sewing
Education Degrees:
Ph.D. in Pharmacy, Université Laval; Master of Science in Environmental Science (Toxicology and Epidemiology), The University of Texas, Health Science Center at Houston; Bachelor of Science in Biochemistry, Rice University
Affiliations Awards:
American Thoracic Society
Work History:
Director of Clinical Research, Clinical Research and Medical Affairs Division, Theratechnologies Inc., St. Laurent, Quebec (2008-2012); Director, Clinical Research (Diabetes and Central Nervous System), BELLUS (Formerly Neurochem Inc.), Laval, Quebec (2007-2008); Director, Clinical Research (Diabetes and Central Nervous System), Neurochem Inc., Laval, Quebec (2006-2007); Director, Clinical Research, ApoPharma, Innovative Drug Division of Apotex Research Inc., Toronto, Ontario (2002-2006); Associate Director (Medical Affairs), Associate Clinical Director and Clinical Manager, GlaxoSmithKline Inc., Mississauga, Ontario, and Montreal, Quebec (1994-2002); Project Leader, Clinical Research, Abbott Laboratories Ltd., Montreal, Quebec (1992-1994); Medical Research Associate, Schering Canada Inc., Montreal, Quebec (1990-1992)
Throughout the duration of your career, what was the one highlight that stood out the most?:
The highlight of her career was recently making extensive scientific contributions, writing new drug approval modules, and making presentations to the U.S. Food and Drug Administration Advisory Committee, leading to the approval of a new drug product. When she reflects on her career across companies and roles, she is also gratified to recognize that she had a variety of accomplishments in each role; as she progressed to more senior positions, she was given more responsibilities and, thus, her achievements per role were more substantial.
Charity:
Breast Cancer Awareness
Number Of Years In Profession:
22
Number Of Years In Current Position:
4
What Does He/She Attribute Success To:
She attributes her success to her love for science, desire to help patients, being open to different opportunities within both biotechnology and pharmaceuticals, and keeping passion in her work.
Why did you become involved in your profession or industry?:
She became involved in her profession because she always had an interest in medicine and loved science. Her father was a physician and she joined him on rounds at the hospital. Eventually, she decided that a career in the development of medicines would satisfy her desire to use her love of science to help patients.
Extended Bio Profile:
In the recent past, Dr. Soulban had seven people reporting to her, including numerous Ph.D.s, a medical writer and a safety officer. She is passionate about developing new medicines, and has played a key role in several successful new drug applications (NDAs) to different regulatory agencies around the world. Her accomplishments include contributing scientifically to various aspects of submissions to the U.S. Food and Drug Administration, presenting applications the FDA Advisory Committee, and gaining drug approval in the United States, which is rare for a Canadian biotech company. She has 22 years of experience in the pharmaceutical and biotechnology industry, and is known as a self-driven, results-oriented professional with strong leadership capabilities. She also possesses excellent communication and team-building skills. Dr. Soulban is married and has two children.
Position Responsibilities and Duties:
Developing and implementing protocols from de novo; Presenting scientific aspects of clinical studies, such as selection of clinical endpoints, inclusion/exclusion criteria, validating scientific concepts with experts and preparing clinical development plans; Managing the safety aspect of the studies, as well as following and ensuring the safety of patients pre- and post-marketing; Researching and developing reports; Writing all scientific publications; Directing a highly scientific team of medical advisers; Participating in strategic events with the company, including due diligence efforts, preparation of various regulatory dossiers, such as new drug applications (NDAs) for the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMEA) and NDS for Health Canada, and presentations to the FDA, EMEA and other regulatory agencies
Awards/Honors:
Award, Fonds pour la Formation des Chercheurs et l'Aide à la Recherche (1987–1990)
Where Will You Be In 5 Years:
In five years, Dr. Soulban plans to be in a vice president role, not just within a clinical setting; she would like to get into medical affairs.